최병철

• 바이오 · 헬스케어

• 2025-현재법무법인(유) 세종 고문
• 2022-2025건강보험심사평가원 진료심사평가위원회 상근심사위원 (책임위원)
• 2020-2022건강보험심사평가원 진료심사평가위원회 상근심사위원 (대표위원)
• 2009-2020건강보험심사평가원 진료심사평가위원회 상근심사위원
• 2000-현재중앙대학교 겸임교수 (제약특성화대학원)
• 1998-2008약사교육연구소 및 도서출판 약연 대표

주요활동

• 미국 약사회 정회원
• 의⸳약사평론가협회 회원
• 대한약학회 이사
• 보건약학협회 명예회장
• 한국사랑나눔공동체 고문

• 2007미국 Colorado 약학대학 임상약학프로그램 3학기 수료
• 2000조선대학교 약학대학 대학원 (약학박사)
• 1994-1997미국 USC 약학대학 단기 연수: 1차(1994), 2차(1995), 3차(1996), 4차(1997)
• 1982연세대학교 보건대학원 (보건학석사)
• 1977중앙대학교 약학대학 (약학사)
• 1973춘천고등학교 졸업

• 1991약사, 미국 캘리포니아주
• 1977약사, 대한민국

저서

• 항암제 임상약리학(2025년 출간 예정)
• 바이오의약품 임상약리학(2022년)
• 약료정보학(2021년, 공저)
• 최신 임상약리학과 치료학(2017년)
• 건강전문직을 위한 약리학(2015년, 공저)
• 임상독성학(2014년, 공저)
• 임상약리학(2013년)
• 일반약 임상약학(2007년)
• 미처 몰랐던 독이 되는 약과 음식(2006년, 편저)
• 임상약학챠트(2000년)

논문

• Pharmacokinetic Changes of Diltiazem, Tolbutamide and Sulfamethoxazole After Ora Administration to Rabbits with Alloxan-Induced Diabetes Mellitus(2000, 박사학위논문)
• A Study on Immune Response by Intoxication of Parathion, Chloroform and 2,6-Dichlorophenol in Rats(1982, 석사학 위논문)

국내

• A Study of Recognition and Acceptance on Pharmacists for the Enforcement of Drug Utilization Review; Yakhak Hoeji, 53(6), 368-376(2009)
• Analysis on Statins for The Treatment of Bone Fracture; Yakhak Hoeji, 53(4), 206-216 (2009)
• Antioxidant Effect of Lutein on N-Nitrosodiethylamine-induced Oxidative Stress in Mice; Yakhak Hoeji, 53(4), 189~193(2009)
• Pharmacokinetic Interaction between Simvastatin and Nicardipine; akhak Hoeji, 19(1), 32-36(2009)
• Antioxidant Activity and Whitening Effects of Acteoside and Isoacteoside; Yakhak Hoeji 53(1), 1-5(2009)
• Effect of Caffeic Acid on the Production of Reactive Oxygen Species in Raw 264.7 Cells; Yakhak Hoeji, 52(6), 441- 445(2008)
• Influence for Pharmacy Management by Health Functional Food after the Separation of Prescribing and Dispensing Practice; Yakhak Hoeji, 53(.2), 45-50(2009)
• A Study for Activation of Pharmacy Oriental Medicine after the Separation of Prescribing and Dispensing Practice; Yakhak Hoeji, 52(6), 471-479(2008)
• Effects of Naringin on the bioavailability of Etoposide in Rats; J. Kor. Pharm. Sci. Vol. 38, No. 5(2008)
• A Survey for the Recognition and Adoption Rates Concerning the Application of Preceptorship into the Pharmacy Education Setting; Kor. J. Clin. Pharm. Vol 18, No 1.(2008)
• Drug Interaction between Praprofen and Aspirin in Rats; Kor. J. Clin. Pharm. 15(1), 50-54(2005)
• Antiinflammatory Activity and Phospholipase A2 Inhibtion of Noni(Morinda cotrifolia) Methanol Extracts; Yakhak Hoeji, 49(5), 405-409(2005)
• Antioxidant Effects of Noni(Morinda cotrifolia) Extracts Treated with Hcl and Trypsin; Yakhak Hoeji, 49(5), 410- 415(2005)
• Effect of Feelch on Blood Alcohol Concentration in Human and Hepatic Alcohol Metabolizing Enzyme Activity in alcohol-Fed Rats; Yakhak Hoeji, 49(4), 340-346(2005)
• Drug Interaction Review of Prescriptions for Outpatients at General Hospital; Yakhak Hoeji, 49(5), 399-404(2005)
• An Analysis on the Factors Affecting Revisit and Defection of Long-term Outpatients in Neighboring Pharmacy of General Hospital; Yakhak Hoeji, 49(6), 449-458(2005)
• Pharmacokinetic Characteristic of Tolperisone in Healthy Korean. Chung Ang J Pharm. Sci. 18, 89-93(2004)
• Pharmcokinetic Changes of Tolbutamide After Oral administration to Rabbits with Alloxan-induced Diabetes Mellitus; J. Kor. Pharm. Sci. Vol. 30, No 2, 107-112(2000)
• Clinical Pharmacokinetics of Vancomycin in Ovarian Cancer Patients; Kor. J. Clin. Pharm., 8(1), 13-18(1998)
• Pharmacokinetics of Cyclosporine in Rabbits with Carbon Tetrachloride and Bile Duct Ligation-induced Hepatic Disorder; Yakhak Hoeji, 42(2), 181-186(1997)
• Chronopharmacokinetics of Vancomycin in Normal Volunteers; Kor. J. Clin. Pharm. 6(2),1-6(1996)
• A Study on Immune Response by Intoxication of Parathion, Chloroform and 2,6-Dichlorophenol in Rats; Yakhak Hoeji, 26(4), 215-222(1982)

국내(SCI-E)

• MLCK and PKC Involvements via Gi and Rho A Protein in Contraction by the Electrical Field Stimulation in Feline Esophageal Smooth Muscle; Korean J. Physiol. Pharmacol.(2010)
• The inhibitory effect of quercetin-3-O-beta-D-glucuronopyranoside on gastritis and reflux esophagitis in rats; Korean J. Physiol. Pharmacol.(2009)
• The effect of Caffeic Acid on Wound healing in Skin-incised Mice; Korean J. Physiol. Pharmacol.(2008)

국외(SCI)

• Development of superparamagnetic iron oxide nanoparticles-embeded chitosan microspheres for magnetic resonsnce-traceable embolotherapy; Biomolecualr & Therapeutics(2009)
• Novel Porous Matrix of Hyaluronic Acid for the Three-dimensional Culture of Chondrocytes; International journal of pharmaceutics(2008)
• Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of Pglycoprotein inhibition by resveratrol; Pharmazie(2008)
• Altered pharmacokinetics of paclitaxel by the concomitant of morin in rats; Int J Pharm; 323(1-2):81-5(2006)
• Effects of Qeurcetin on the pharmacokinetics of Oral Cyclosporine; Am J Health-Syst Pharm,Vol 61 Nov 15(2004)
• Pharmacokinetic Changes of Oral Sulfamethoxazole in Rabbits with Diabetes Mellitus-induced by Alloxan; Reaseach Communications in Molecular Pathology and Pharmacology Vol. 108, NOS. 5& 6(2000)

국외발표

• “Patient counseling of Over-The-Counter drugs to enhance the pharmacist’s role” The 7th Asia Conference on Clinical Pharmacy. July 2007, Shaghai, China
• "The Pharmacist’Role in Significant Hazardous Interactions of Duplicative Therapy Focusing Antipsychotics and Antibiotics for Drug Utilization Review"; International Pharmaceutical Federation (FIP) 65th Congress. Cairo, Egypt. September 2-8, 2005
• "Effects of Quercetin on the Pharmacokinetics of Cyclosporine in Human Subjects"; International Pharmaceutical Federation (FIP) 63rd Congress. Sydney, Australia. September 4-9, 2003
• "Drug Interaction of Cimetidine and Cyclosporine in Human Subjects"; The 18th Federation of Asian Pharmaceutical Associations(FAPA) Congress. Sydney, Australia. October 26-30, 2000
• "Internet Program for Community Pharmacists"; The 17th Federation of Asian Pharmaceutical Associations(FAPA) Congress. Mumbai, India. December 10-13, 1998